Connect live...

Select the exhibitor's booth below and get connected live.

Click on "Edit" in the right panel to replace this with your own HTML code

Other exhibitors

Information

iCFO Information Booth How can we help?
Entrepreneur

Welton Pharma Welton is utilizing Apisolex drug delivery technology to optimize pharmaceutical drug products
Entrepreneur

Opus Genetics Envisioning a new future for patients with inherited retinal diseases
Entrepreneur

STRATAFOLIO Total Commercial Property Management Platform
Entrepreneur

PROOF Hard Ice Cream PROOF will be among the most highly recommended gourmet brands in the world
Entrepreneur

SeekingSimple "Improved health through better processed food choices to address food related disease for 230M in the US and the resulting $1.1T problem for healthcare payors"
Entrepreneur

Soon Crypto Investing Automated & Easy
Entrepreneur

Schmaltz Restaurant Group Spread Jewish Deli Goodness Everywhere
Entrepreneur

Digital Asset Management A coin for the future of crypto Investing
Entrepreneur

Nutr Changing the way we milk
Entrepreneur

Vasa Therapeutics Novel therapeutics for unmet medical needs in cardiovascular medicine
Entrepreneur

Gel Dynamics The only fully dynamic and continuous wheel balancing solution destined to reshape the trucking industry while contributing to a greener planet.
Entrepreneur

Torque3 Transformative Stroke Recovery
Entrepreneur

Adlore Introducing SenLore - A Novel Device to Treat and Monitor Diabetic Foot Ulcers
Entrepreneur

Kurve Therapeutics The Future of Systemic and Central Nervous System (CNS) Therapies - Bringing solutions to clinical unmet needs

Event DealConnect 360: The Ultimate Deal Room for Real Results! is over.
Join us next time to meet Noel Greenberger!

About Nob Hill Therapeutics

Nob Hill Therapeutics

Pioneering Respiratory Patient Care

Available from 12:00 PM - 4:00 PM (US/Pacific)

http://www.nobhilltherapeutics.com/

noel.greenberger@nobhilltherapeutics.com

+1 312-493-7881

Nob Hill Therapeutics is a healthcare startup that is developing new technologies and therapies for lung-related diseases that can’t be effectively treated today. These diseases impact millions of patients, and the annual market potential for several of these diseases is substantial (e.g., lung cancer - $30b, Cystic Fibrosis - $13b, Invasive fungal infections - $9b). Nob Hill has developed a new drug inhalation device platform that solves many disadvantages with today’s technologies and is also working on accompanying drug-device combination products that will serve as PoC for the technology (with addressable markets in the US of $1.75b annual sales). Nob Hill’s team is highly experienced with developing and commercializing respiratory products (combined experience of 100+ years).